Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Oct 31:7:137.
doi: 10.3389/fendo.2016.00137. eCollection 2016.

Paraventricular Hypothalamic Mechanisms of Chronic Stress Adaptation

James P Herman  1 , Jeffrey G Tasker  2
Affiliations
Review

Paraventricular Hypothalamic Mechanisms of Chronic Stress Adaptation

James P Herman et al. Front Endocrinol (Lausanne). .

Abstract

The hypothalamic paraventricular nucleus (PVN) is the primary driver of hypothalamo-pituitary-adrenocortical (HPA) responses. At least part of the role of the PVN is managing the demands of chronic stress exposure. With repeated exposure to stress, hypophysiotrophic corticotropin-releasing hormone (CRH) neurons of the PVN display a remarkable cellular, synaptic, and connectional plasticity that serves to maximize the ability of the HPA axis to maintain response vigor and flexibility. At the cellular level, chronic stress enhances the production of CRH and its co-secretagogue arginine vasopressin and rearranges neurotransmitter receptor expression so as to maximize cellular excitability. There is also evidence to suggest that efficacy of local glucocorticoid feedback is reduced following chronic stress. At the level of the synapse, chronic stress enhances cellular excitability and reduces inhibitory tone. Finally, chronic stress causes a structural enhancement of excitatory innervation, increasing the density of glutamate and noradrenergic/adrenergic terminals on CRH neuronal cell somata and dendrites. Together, these neuroplastic changes favor the ability of the HPA axis to retain responsiveness even under conditions of considerable adversity. Thus, chronic stress appears able to drive PVN neurons via a number of convergent mechanisms, processes that may play a major role in HPA axis dysfunction seen in variety of stress-linked disease states.

Keywords: corticotropin-releasing hormone; glucocorticoids; hypothalamo–pituitary–adrenal axis; neuroendocrine system; vasopressin.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Plasticity across the hypothalamo–pituitary–adrenocortical (HPA) axis following chronic stress. HPA axis activation is initiated by CRH (and AVP)-containing neurons in the medial parvocellular paraventricular nucleus (PVN), which releases ACTH secretagogues into hypophysial portal vessels in the median eminence. ACTH is released from the pituitary and travels via the systemic circulation to the adrenal cortex, where it causes the synthesis and secretion of glucocorticoids [e.g., cortisol or corticosterone (CORT)]. Under conditions of chronic stress, there are marked changes in cellular reactivity across the HPA axis, including (1) increased CRH and AVP expression in, and enhanced excitability of CRH neurons in the PVN, (2) increased CRH/AVP colocalization and CRH release in the median eminence, (3) increased CRHR1 and V1b gene expression in and sensitivity to CRH and AVP of pituitary corticotropes, and (4) adrenal hypertrophy and enhanced adrenal sensitivity to ACTH. All changes are consistent with increased potential for HPA axis activation. Modified from Myers et al. (4), with permission.
Figure 2
Figure 2
Cellular plasticity in parvocellular paraventricular nucleus neurons following chronic stress. Chronic stress causes a number of neuroplastic changes in parvocellular neurons consistent with increased excitability, including (1) increased number of (excitatory) glutamergic (VGluT2) terminal appositions, (2) enhanced excitatory synaptic inputs (increase in mEPSC frequency), (3) enhanced NR2A/NR2B ratio, predictive of increased NMDA receptor calcium permeability, and (4) increased number of (putative excitatory) norepinephrine/epinephrine terminal appositions. In addition, there is evidence for reduced inhibition of the PVN neurons, in terms of (1) reduced GABAergic synaptic inputs (decrease in mIPSC frequency), (2) decreased expression of synaptic and extrasynaptic GABAA receptor subunits, (3) decreased cannabinoid type 1 receptor signaling, and (4) reduced GR expression/signaling, in some, but not all, studies.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Myers B, Mcklveen JM, Herman JP. Glucocorticoid actions on synapses, circuits, and behavior: implications for the energetics of stress. Front Neuroendocrinol (2014) 35:180–96.10.1016/j.yfrne.2013.12.003 - DOI - PMC - PubMed
    1. Keller-Wood ME, Dallman MF. Corticosteroid inhibition of ACTH secretion. Endocr Rev (1984) 5:1–24.10.1210/edrv-5-1-1 - DOI - PubMed
    1. Antoni FA. Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotropin-releasing factor. Endocr Rev (1986) 7:351–78.10.1210/edrv-7-4-351 - DOI - PubMed
    1. Myers B, Mcklveen JM, Herman JP. Neural regulation of the stress response: the many faces of feedback. Cell Mol Neurobiol (2012) 32:683–94.10.1007/s10571-012-9801-y - DOI - PMC - PubMed
    1. Whitnall MH, Mezey E, Gainer H. Co-localization of corticotropin-releasing factor and vasopressin in median eminence neurosecretory vesicles. Nature (1985) 317:248–50.10.1038/317248a0 - DOI - PubMed

LinkOut - more resources